Skip to main content
SpringerLink
Log in

Drug Safety in Cardiovascular Disease: A Call to ACTION

  • Editorial
  • Published:
Cardiovascular Drugs and Therapy Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Graham DJ, Staffa JA, Shatin D, et al. Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs. JAMA 2004;292:2585–2590.

    Article  CAS  PubMed  Google Scholar 

  2. Bresalier RS, Sandler RS, Quan H, et al. Adenomatous Polyp Prevention on Vioxx (APPROVe) Trial Investigators. Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. N Engl J Med 2005;352:1092–1102.

    Article  CAS  PubMed  Google Scholar 

  3. Solomon SD, McMurray JJ, Pfeffer MA, et al. Adenoma Prevention with Celecoxib (APC) Study Investigators. Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention. N Engl J Med 2005;352:1071–1080.

    Article  CAS  PubMed  Google Scholar 

  4. Sackner-Bernstein JD, Kowalski M, Fox M, Aaronson K. Short-term risk of death after treatment with nesiritide for decompensated heart failure: A pooled analysis of randomized controlled trials. JAMA 2005;293:1900–1905.

    Article  CAS  PubMed  Google Scholar 

  5. Nissen SE, Wolski K, Topol EJ. Effect of muraglitazar on death and major adverse cardiovascular events in patients with type 2 diabetes mellitus. JAMA 2005;294:2581–2586.

    Article  CAS  PubMed  Google Scholar 

  6. Poole-Wilson PA, Lubsen J, Kirwan BA, et al. Weber S. A Coronary disease Trial Investigating Outcome with Nifedipine gastrointestinal therapeutic system investigators. Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial): Randomised controlled trial. Lancet 2004;364:849–857.

    Article  CAS  PubMed  Google Scholar 

  7. Poole-Wilson PA, Kirwan BA, Voko Z, de Brouwer S, van Dalen F, Lubsen J. Safety of Nifedipine GITS in stable angina: The ACTION trial. Cardiovascular Drugs and Therapy 2006; (in press).

  8. Furberg CD, Psaty BM, Meyer JV. Nifedipine. Dose-related increase in mortality in patients with coronary heart disease. Circulation 1995;92:1326–1331.

    CAS  PubMed  Google Scholar 

  9. Wang PS, Schneeweiss S, Avorn J, et al. Risk of death in elderly users of conventional vs. atypical antipsychotics medications. N Engl J Med 2005;353:2335–2341.

    Article  CAS  PubMed  Google Scholar 

  10. Topol EJ. Arthritis medicines and cardiovascular events–“house of coxibs”. JAMA 2005;293:366–368.

    Article  CAS  PubMed  Google Scholar 

  11. Ray WA. Observational studies of drugs and mortality. N Engl J Med 2005;353:2319–2321.

    Article  CAS  PubMed  Google Scholar 

  12. McMurray J, Murdoch D. Calcium-antagonist controversy: The long and short of it? Lancet 1997;349:585–586.

    Article  CAS  PubMed  Google Scholar 

  13. Kostis JB, Shelton B, Gosselin G, et al. Adverse effects of enalapril in the Studies of Left Ventricular Dysfunction (SOLVD). SOLVD Investigators. Am Heart J 1996;131:350–355.

    Article  CAS  PubMed  Google Scholar 

  14. Pfeffer MA, Keech A, Sacks FM, et al. Safety and tolerability of pravastatin in long-term clinical trials: Prospective Pravastatin Pooling (PPP) Project. Circulation 2002;105:2341–2346.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medical Cardiology & Honorary Consultant Cardiologist, Department of Cardiology, Western Infirmary, Glasgow, G11 6NT, Scotland, UK

    John J. V. McMurray (Professor)

  2. Medical Cardiology & Honorary Consultant Cardiologist, Department of Cardiology, Western Infirmary, Glasgow, G11 6NT, Scotland, UK

    John J. V. McMurray (Professor)

Authors
  1. John J. V. McMurray
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

McMurray, J.J. Drug Safety in Cardiovascular Disease: A Call to ACTION. Cardiovasc Drugs Ther 20, 9–10 (2006). https://doi.org/10.1007/s10557-006-6690-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10557-006-6690-7

Search

Navigation